VLA 0.00% $1.75 viralytics limited

more virotherapy news, page-4

  1. 156 Posts.
    Honestly - my one frustration with this company is the lack of effort on the publicity front (other than our lone campaigner, the speculator). Why wouldn't you mention the name of the company in the interview or go out and publicise the company in the wake of the nature paper. Do they genuinely want to excite third party interest in this product?
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.